The clinical characteristics and prognosis of patients with SAPHO syndrome--a real-world cohort study

被引:4
|
作者
Duan, Hongji [1 ]
Gao, Shuang [2 ]
Zhang, Lihua [3 ]
Song, Le [4 ]
Zhai, Jiayu [5 ]
Deng, Xiaoli [1 ]
机构
[1] Capital Med Univ, Beijing Jishuitan Hosp, Dept Orthoped Med, 31 Xinjiekou East St, Beijing 100035, Peoples R China
[2] Peking Univ Third Hosp, Lymphoma Ctr, Dept Hematol, Beijing, Peoples R China
[3] Peking Univ Third Hosp, Dept Radiol, Beijing, Peoples R China
[4] Peking Univ Third Hosp, Dept Nucl Med, Beijing, Peoples R China
[5] Peking Univ Third Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China
关键词
Iguratimod; Outcome; SAPHO syndrome; Treatment; NF-KAPPA-B; OSTEITIS SAPHO; SINGLE-CENTER; HYPEROSTOSIS; PUSTULOSIS; ACNE; SYNOVITIS; CELLS; T-614; BONE;
D O I
10.1007/s10067-023-06782-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesWe aimed to analyze the clinical characteristics and outcomes of patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.MethodsThe clinical records of 64 patients with SAPHO syndrome were collected, and the treatment and outcomes of 27 patients were followed up. The patients were divided into three groups according to the site of bone lesions: only anterior chest wall (ACW) involvement, only spinal involvement, and bone lesion involvement at both sites. The clinical characteristics and outcomes were compared. The clinical characteristics of the patients with and without peripheral joint involvement were compared.ResultsAmong all patients, 31.25% (20/64) had only ACW involvement, 15.63% (10/64) had only spinal involvement, and 53.12% (34/64) had both ACW and spinal involvement. Peripheral joint involvement was observed in 25.00% (16/64) of the patients. Patients with only spinal involvement were older than those with only ACW involvement (p = 0.006). Patients with both ACW and spinal involvement were older than those with only ACW involvement (p = 0.002) and had a longer diagnosis delay (p = 0.015). Patients with peripheral joint involvement were younger than those without peripheral joint involvement (p = 0.028). During follow-up, 88.89% (24/27) of patients had good outcomes. Twenty-two patients were treated with non-steroidal anti-inflammatory drugs + Iguratimod (IGU), and the outcomes of 90.91% (20/22) improved.ConclusionsA relationship may exist between the sites of bone lesions and clinical characteristics of patients with SAPHO syndrome. The clinical outcomes of these patients may be good, and IGU may be effective in treating SAPHO syndrome.Key Points center dot This study is the first long-term follow-up on the effectiveness of iguratimod in treating patients with SAPHO.center dot This study revealed that patients with SAPHO and different bone lesion sites may present with different clinical characteristics.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 50 条
  • [31] Differences in clinical characteristics and outcomes in real-world HFpEF patients according to clinical definitions
    Oo, M. M.
    Lim, R. E. N.
    Lang, C. C.
    Mordi, I. R.
    EUROPEAN HEART JOURNAL, 2021, 42 : 745 - 745
  • [32] Effect of interruption or discontinuation of endocrine therapy on the prognosis of breast cancer patients: a cohort study using the real-world database
    Huang, Ya
    Chen, Jie
    Wu, Yunhao
    CANCER RESEARCH, 2024, 84 (09)
  • [33] The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China
    Xiao, Jinyan
    Cai, Zihong
    Wang, Hao
    Li, Xuekai
    Zhou, Biqi
    Liu, Yujie
    Wang, Ying
    Xu, Peipei
    Wang, Li
    Wu, Depei
    Dou, Liping
    Zhou, Hongsheng
    Xu, Yang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Clinical Characteristics, Treatment, and Prognosis of Osteoarticular Brucellosis: A Retrospective Real-World Study in Shenyang, China, 2014-2019
    Li, Dan
    Yuan, Guanmin
    Wang, Yan O.
    Wang, Hongyu
    Zhang, Qiran
    Wang, Yan A.
    Gu, Ye
    Zhang, Haocheng
    Zhang, Yi
    Song, Jieyu
    Fu, Zhangfan
    Lin, Ke
    Qiu, Chao
    Zhou, Yang
    Fan, Mingxiang
    Zhao, Yuanhan
    Guo, Jinxin
    Jiang, Ning
    Ai, Jingwen
    Liu, Hongyan
    Zhang, Wenhong
    FOODBORNE PATHOGENS AND DISEASE, 2025, 22 (02) : 86 - 96
  • [35] Assessment of geriatric and clinical domains for development and validation of a novel nomogram to predict the prognosis of older patients with breast cancer: a real-world retrospective cohort study
    Lin, Yan
    Song, Yu
    Xu, Ying
    Wang, Changjun
    Xu, Yali
    Huang, Xin
    Sun, Qiang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] CHARACTERISTICS AND OUTCOMES IN A REAL-WORLD COHORT OF RHEUMATOID ARTHRITIS PATIENTS WITH COVID-19
    Ye, Y.
    Yue, X.
    Krueger, W.
    Wegrzyn, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 860 - 860
  • [37] Characteristics of a Real-World Canadian Cohort of Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone
    Ryerson, C.
    Kolb, M. R. J.
    Cox, G. P.
    Shapera, S.
    Swigris, J. J.
    Fell, C. D.
    O'Brien, M.
    Yang, M.
    Cabalteja, C.
    Mendoza, O. Moran
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [38] Real-World Use and Outcomes of Oral Antiplatelets Among Patients with Acute Coronary Syndrome: A Retrospective Cohort Study
    Samuel K. Peasah
    Douglas Mager
    Kiraat D. Munshi
    Yan Huang
    Rochelle Henderson
    Elizabeth C. S. Swart
    Lynn Neilson
    Chester B. Good
    Drugs - Real World Outcomes, 2022, 9 : 121 - 127
  • [39] A Retrospective Cohort Study to Determine Real-World Treatment Patterns in Patients with Sézary Syndrome in the United States
    Ristuccia, Robert
    Zhao, Yang
    Chang, Chunlan
    Zhou, Huanxue
    Takahashi, Takeshi
    Nomura, Takanobu
    Dennis, Eslie
    Akilov, Oleg
    ONCOLOGY AND THERAPY, 2024, 12 (04) : 775 - 786
  • [40] Real-World Use and Outcomes of Oral Antiplatelets Among Patients with Acute Coronary Syndrome: A Retrospective Cohort Study
    Peasah, Samuel K.
    Mager, Douglas
    Munshi, Kiraat D.
    Huang, Yan
    Henderson, Rochelle
    Swart, Elizabeth C. S.
    Neilson, Lynn
    Good, Chester B.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 121 - 127